If this email is not displayed correctly please click here

Healthcare & Life Sciences

30 September 2020
David Schwartz 8 important life sciences IP issues for innovators doing business in Canada

Canada - Smart & Biggar

The US-Canada border is the longest border between any two countries and US goods and services trade with Canada totalled an estimated US$718.5 billion in 2018, possibly the largest bilateral trade volume between two individual countries. Given the extensive integration of the Canadian and US economies, US life sciences companies can expect to have Canadian business interests. This article highlights eight life sciences IP issues of importance for innovators doing business in Canada.

Author: David Schwartz
Read more

Recent updates

Armand Aviges Suspension of decision granting Baclocur market authorisation when decision is based on compromise rather than scientific knowledge

France - Altana

Authors: Armand Aviges, Delphine Lapillonne
Amy de La Lama Telehealth privacy issues due to COVID-19

USA - Baker McKenzie

Author: Amy de La Lama
Petter Larsson Objective necessity to rebox in parallel trade and implementation of EU Falsified Medicines Regulation

Sweden - Westerberg & Partners Advokatbyrå Ab

Authors: Petter Larsson, Jonas Löfgren
Rainer Herzig Constitutional Court overrules COVID-19 restrictions

Austria - Preslmayr Attorneys at Law

Author: Rainer Herzig
Constantin Herfurth Cybersecurity in healthcare sector – Q&A on data breaches in relation to medical devices

European Union - Eversheds Sutherland (International) LLP

Authors: Constantin Herfurth, Magdalena Kotyrba
José Alberto Campos Vargas Outpatient medical care facility infrastructure and equipment in times of technological advances

Mexico - Sanchez DeVanny Eseverri SC

Authors: José Alberto Campos Vargas, Ernesto Vega Saldivar